True rate of mineralocorticoid receptor antagonists‐related hyperkalemia in placebo‐controlled trials: A meta‐analysis
Sign Up to like & getrecommendations! Published in 2017 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.03.011
Abstract: Background Mineralocorticoid receptor antagonists (MRA) improve survival in heart failure with reduced ejection fraction but are often underused, mostly due to concerns of hyperkalemia. Because hyperkalemia occurs also on placebo, we aimed to determine the… read more here.
Keywords: hyperkalemia; rate; placebo; mra related ... See more keywords